Learn / ARCT
NASDAQ: ARCT
Arcturus Therapeutics Holdings (ARCT) stock, explained like you're 5
Arcturus Therapeutics Holdings trades on the Nasdaq under the ticker ARCT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 391 million dollars.
- Ticker
- ARCT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Small cap, about 391 million dollars
Is Arcturus Therapeutics Holdings a small, medium or large cap company?
No. Arcturus Therapeutics Holdings is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 391 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Arcturus Therapeutics Holdings makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ARCT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- ARCT Surges Over 60% Toward Best Week In Year As Moderna Cancer Win Lifts Sector Retail Says Arcturus Getting ‘Harder To Dismiss’ (Stocktwits)
- Precision Trading with Arcturus Therapeutics Holdings Inc. (ARCT) Risk Zones (Stock Traders Daily)
- Arcturus will take part in five investor events this September (Stock Titan)
- ARCT Nov 2026 17.500 call (ARCT261120C00017500) stock price, news, quote and history (Yahoo Finance UK)
- Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar? (Yahoo Finance)
Follow ARCT in your daily brief
Each trading day at 5 PM ET we post what happened to Arcturus Therapeutics Holdings and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ARCT
Questions about Arcturus Therapeutics Holdings stock
What does Arcturus Therapeutics Holdings do?
Arcturus Therapeutics Holdings trades on the Nasdaq under the ticker ARCT. It is a small cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 391 million dollars.
What is the ticker symbol for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings trades under the ticker ARCT on the Nasdaq.
What is Arcturus Therapeutics Holdings's market cap?
Arcturus Therapeutics Holdings is a small cap stock with a market cap of about 391 million dollars.
How does Arcturus Therapeutics Holdings make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ARCT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ARCT stock every day?
Add ARCT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.